Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses
2022 · Cell Reports · 46 citations
https://doi.org/10.1016/j.celrep.2022.110345
D
David Agapiou
UNSW Sydney(AU)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
539
Citations
12
h-index
15
i10-index
David Agapiou is an academic researcher from UNSW Sydney. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Hepatitis C virus research. The author has an h-index of 12, co-authored 29 publications.
ORCID: 0000-0003-3913-3751Papers by this author
worksA systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines
2023 · Cell Reports Medicine · 44 citations
https://doi.org/10.1016/j.xcrm.2023.100971
A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease
2025 · Immunity · 15 citations
https://doi.org/10.1016/j.immuni.2024.12.011
B-cell characteristics define HCV reinfection outcome
2024 · Journal of Hepatology · 8 citations
https://doi.org/10.1016/j.jhep.2024.04.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat